EphA4 forms a heteroreceptor complex with fibroblast growth factor receptor 1 (FGFR1) in glioma cells, and the EphA4-FGFR1 complex potentiates FGFR-mediated downstream signaling [17]. Here, EPHA4 is linked to central nervous system cancer.